Peptides News and Research

RSS

UArizona researchers get closer to developing a safe, effective non-opioid pain reliever

Researchers at the University of Arizona Health Sciences are closer to developing a safe and effective non-opioid pain reliever after a study showed that a new compound they created reduces the sensation of pain by regulating a biological channel linked to pain.

10 Nov 2021

COVID-19 drug candidate with wide-ranging antiviral activity

A new study investigated the antiviral activity and mechanism of action of Brilacidin against multiple human coronaviruses.

9 Nov 2021

Discovery of potent neutralizing antibodies against SARS-CoV-2 variants

In a recent study, the researchers identify and characterize mAbs that are effective against the wild-type SARS-CoV-2 strain and B.1.351 variant.

8 Nov 2021

Studying influenza A virus and peptide interactions with electrically controllable DNA nanoconstructs

German scientists used DNA nanolevers to target the interaction between a peptide known as PeB and influenza A.

3 Nov 2021

New Canadian serology solution for SARS-CoV-2 infections and vaccination

A new study developed a “Made-in-Canada” solution for enabling scalable and reproducible SARS-CoV-2 serology.

31 Oct 2021

Experts create deep learning network capable of detecting disease biomarkers with high accuracy

Researchers are developing a deep learning network capable of detecting disease biomarkers with a much higher degree of accuracy.

28 Oct 2021

COVID-19 and subacute neuropsychiatric symptoms in adolescents

A new paper discusses neurologic symptoms in children with COVID-19.

27 Oct 2021

Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccination amongst healthcare workers

The heterologous ChAd/BNT combination confers better protection against SARS-CoV-2 infection than the homologous BNT/BNT combination in a real-world observational study of healthcare workers.

27 Oct 2021

bit.bio expands Board of Directors with appointment of entrepreneurs and Nobel Laureate

Today bit.bio welcomed three new members to its Board of Directors, who bring their respective experience of turning world-class science into new industries.

From bit.bio 27 Oct 2021

Enzymes with diverse functions can be rationally harnessed to offer traceless protein synthesis

A multi-enzyme platform is developed for sequence-unconstrained traceless protein synthesis and modification with either synthetic peptides or recombinant proteins, according to a new study out of Chinese Academy of Sciences and Fresenius Kabi.

22 Oct 2021

Researchers discover how Staphylococcus aureus protects itself against important antibiotic

The skin bacterium Staphylococcus aureus often develops antibiotic resistance. It can then cause infections that are difficult to treat.

21 Oct 2021

Cat bacteria likely to form the basis for novel therapeutics against severe skin infections

Researchers at University of California San Diego School of Medicine used bacteria found on healthy cats to successfully treat a skin infection on mice. These bacteria may serve as the basis for new therapeutics against severe skin infections in humans, dogs and cats.

20 Oct 2021

Many people's T-cells recognize the same components of SARS-CoV-2

A new study published on the bioRxiv* preprint aimed to identify highly immunoprevalent CD8 T-cell epitopes specific to SARS-CoV-2 that are confirmed to be endogenously processed and presented on frequently expressed HLA alleles.

18 Oct 2021

UC Davis researchers publish the first atlas of metabolites in the mouse brain

The first atlas of metabolites in the mouse brain has been published by a team led by UC Davis researchers.

18 Oct 2021

Research indicates that mRNA vaccine-induced T cells respond robustly to new SARS-CoV-2 variants

To address the gaps in the knowledge, a team of researchers from the University of California and the Gladstone Institute of Virology conducted 39-parameter phenotyping by cytometry by time of flight (CyTOF) on 33 longitudinal specimens from 11 mRNA-vaccinated individuals, of which six had previously been infected and recovered from COVID-19.

18 Oct 2021

Fibrin immunotherapy may resolve blood clotting induced by SARS-CoV-2

A group of researchers from the United States discovered that the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce the formation of highly inflammatory blood clots amenable to neutralization by a fibrin-targeting monoclonal antibody – opening the door for a completely new strategy to reduce thrombotic inflammation in coronavirus disease 2019 (COVID-19).

17 Oct 2021

Peptides News and Research

UArizona researchers get closer to developing a safe, effective non-opioid pain reliever

COVID-19 drug candidate with wide-ranging antiviral activity

Discovery of potent neutralizing antibodies against SARS-CoV-2 variants

Studying influenza A virus and peptide interactions with electrically controllable DNA nanoconstructs

New Canadian serology solution for SARS-CoV-2 infections and vaccination

Experts create deep learning network capable of detecting disease biomarkers with high accuracy

COVID-19 and subacute neuropsychiatric symptoms in adolescents

Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccination amongst healthcare workers

bit.bio expands Board of Directors with appointment of entrepreneurs and Nobel Laureate

Enzymes with diverse functions can be rationally harnessed to offer traceless protein synthesis

Researchers discover how Staphylococcus aureus protects itself against important antibiotic

Cat bacteria likely to form the basis for novel therapeutics against severe skin infections

Many people's T-cells recognize the same components of SARS-CoV-2

UC Davis researchers publish the first atlas of metabolites in the mouse brain

Research indicates that mRNA vaccine-induced T cells respond robustly to new SARS-CoV-2 variants

Fibrin immunotherapy may resolve blood clotting induced by SARS-CoV-2

Sleep-enhancing peptides in cow’s milk could help develop new, natural sleep remedies

COVID-19 vaccination induces transient increase in cellular and antibody responses to S1 antigenic sequence

Rapid measurement of SARS-CoV-2 spike T-cells

COVID-19 vaccination elicits broader antibody response to SARS-CoV-2 spike than infection

Editorial Focus eBook - Peptides and Oligonucleotides (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News